Historical Performance of LEAPS Strategies

Long-term options have been around since 1990, yet most investors treat them like new tech. Here's the truth: decades of data reveal when LEAPS work, when they don't, and why value investors who used them correctly outperformed those who didn't.

TL;DR

• LEAPS thrived during multi-year bull runs: Quality companies with steady earnings growth delivered amplified returns through long-dated options
• They struggled during quick crashes: 2008 and 2020 showed that even 2-year options can expire worthless if timing is off
• Best use case: undervalued quality stocks: Historical winners combined LEAPS with companies trading below intrinsic value
• Time decay matters more than expected: Even with 1-2 years to expiration, theta decay eroded 30-40% of extrinsic value in the first year
• Rolling worked when fundamentals held: Investors who rolled LEAPS on solid businesses recovered better than those who let positions expire

The Long View: LEAPS Since 1990

When LEAPS first launched, they were marketed as "stock substitutes" for those who wanted exposure without tying up full capital. Early adopters in the 1990s bull market crushed it, companies like Microsoft, Cisco, and Dell (all trading well below fair value at the time) saw their LEAPS calls multiply 3x to 5x before expiration.

But here's what the marketing didn't mention: for every winner, there were dozens of LEAPS that expired worthless on overhyped stocks that never delivered earnings growth. The lesson? LEAPS amplify what's already there. If the business is solid and undervalued, LEAPS can supercharge returns. If it's speculative, they accelerate losses.

The Dot-Com Crash (2000-2002)

This period taught investors the hardest lesson: momentum doesn't care about your expiration date. Many tech LEAPS bought in 1999-2000 expired worthless by 2002, even with 2-year timeframes. Stocks that fell 70-90% didn't recover before options expired.

The winners? Value investors who bought LEAPS on beaten-down blue chips trading at 8-10x earnings in 2002-2003. Companies like Johnson & Johnson, Procter & Gamble, and Coca-Cola, businesses with durable cash flow that the market temporarily ignored. Those LEAPS doubled or tripled as the market recovered, amplifying returns without the full stock price risk.

Key takeaway: LEAPS work best when you enter during fear, not euphoria, and only on companies with proven staying power.

The 2008 Financial Crisis

The financial crisis was a stress test for every strategy. LEAPS holders who bought in 2006-2007 got crushed. Even solid companies saw their stocks drop 40-60%, and most LEAPS expired worthless because the recovery took 3-4 years, longer than any LEAP contract.

But here's where it gets interesting: investors who bought LEAPS in early 2009 on quality companies trading at 5-7x earnings (think Wells Fargo, American Express, or 3M) saw those contracts multiply 4x to 6x by 2010-2011. The amplification worked because the businesses were fundamentally sound, just temporarily mispriced.

Some investors rolled their 2008 LEAPS into 2010-2011 contracts during the crash, effectively extending their timeframe. Those who rolled on companies with strong balance sheets and predictable earnings recovered their losses. Those who rolled on banks with shaky balance sheets didn't.

Key takeaway: LEAPS are not set-and-forget. Active management, rolling when fundamentals remain strong, saved investors who started with bad timing.

The 2010s Bull Market

From 2010 to 2019, LEAPS delivered their best stretch. Companies like Apple, Microsoft, and Visa (all trading below intrinsic value in 2010-2012) saw their LEAPS contracts multiply 5x to 10x for those who bought during downturns or consolidations.

The standout pattern: investors who bought LEAPS on companies with 15%+ annual earnings growth and held until they reached fair value did better than those who held the stock outright. The leverage worked because time was on their side, and the businesses delivered.

But even in a bull market, LEAPS on overvalued companies or speculative names failed. The common thread? Valuation mattered more than market sentiment. Buying LEAPS on a stock at 30x earnings rarely worked, even in a bull market.

The 2020 Pandemic Crash & Recovery

March 2020 wiped out nearly every LEAPS contract bought in 2019. Stocks fell 30-40% in weeks, and even 1-2 year LEAPS went deep out-of-the-money. But within 6 months, those same stocks recovered, and LEAPS contracts that survived (or were rolled) delivered 3x to 5x returns by 2021.

The key difference? Companies with strong balance sheets and recurring revenue (Microsoft, Amazon, Costco) recovered faster than cyclical businesses (airlines, energy, retail). Investors who applied a margin of safety, only using LEAPS on companies with low debt and predictable cash flow, survived the drop and captured the recovery.

Key takeaway: Even the best LEAPS strategy can't predict black swan events. The survivors were those who only used LEAPS on wonderful companies with fortress balance sheets.

What the Data Shows About LEAPS

Looking back at 30+ years, here's what worked:

• Entry timing mattered: LEAPS bought during market fear or corrections (P/E ratios below historical averages) outperformed those bought during euphoria
• Quality over speculation: LEAPS on companies with 10+ year earnings histories, low debt, and economic moats delivered positive returns 70% of the time
• Rolling extended wins: Investors who rolled losing LEAPS on solid companies recovered 60-70% of the time, those who let them expire lost everything
• Leverage cut both ways: LEAPS amplified gains by 3-5x in bull markets but wiped out investors who used them on weak businesses

The Behavioral Lessons

Historical data also reveals investor mistakes. The most common: chasing momentum instead of value. Investors who bought LEAPS on hot stocks (Tesla in 2020, Nvidia in 2023) often overpaid and saw their contracts decay as stocks consolidated. Meanwhile, those who bought LEAPS on boring, undervalued companies (think Berkshire Hathaway, Costco, or UnitedHealth during dips) quietly compounded wealth.

Another pattern: overtrading. Investors who cycled through LEAPS every 3-6 months underperformed those who bought once, waited 18-24 months, and let the business deliver. LEAPS reward patience, not activity.

What Could Go Wrong?

Even with solid historical performance, LEAPS carry risks:

• Time runs out: If the stock doesn't reach your target before expiration, you lose everything, unlike stock ownership which can wait indefinitely
• Volatility collapse: If IV drops after you buy, your LEAP loses value even if the stock price stays flat
• Rolling costs: Every roll requires buying more time premium, which eats into returns if the stock doesn't move
• Black swan events: Unpredictable crashes (2008, 2020) can wipe out even the best LEAPS strategies if timing is off
• Overvaluation risk: If you buy LEAPS on a stock above fair value, even a good company won't save you

Mitigations: Only buy LEAPS on companies trading below intrinsic value, use a margin of safety (target 20-30% undervaluation), set reminders to review positions every 6 months, and be willing to roll or exit if fundamentals change.

Next Steps

• Review historical winners: Study companies that delivered strong LEAPS returns (Microsoft, Apple, Costco) and note their common traits (low debt, predictable earnings, economic moats)
• Analyze your candidates: Use valuation models to ensure your LEAPS targets are undervalued, not just "popular"
• Set rolling rules: Decide in advance when you'll roll (e.g., if fundamentals remain strong but the stock is flat after 12 months)
• Track your timing: Keep a journal of entry points and compare them to market P/E ratios to see if you're buying during fear or greed
• Read more: Check out Intrinsic Value and LEAPS to understand how to value LEAPS contracts, and When NOT to Use LEAPS to avoid common mistakes